Hochner-Celnikier, D <br/><br/>
Tamoxifen exerts oestrogen-agonistic effects on proliferation and plasminogen activation, but not on gelatinase activity, glycogen metabolism and p53 protein expression, in cultures of oestrogen-responsive human endometrial adenocarcinoma cells.  [electronic resource] 

 -  Molecular human reproduction  Dec 1997 
 - 1019-27 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1360-9947 
<br/><br/><label>Standard No.: </label>10.1093/molehr/3.12.1019  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--enzymology<br/>Cell Division--drug effects<br/>Drug Combinations<br/>Endometrial Neoplasms--enzymology<br/>Enzyme Activation--drug effects<br/>Estradiol--agonists<br/>Female<br/>Gelatinases--metabolism<br/>Glycogen--metabolism<br/>Glycogen Synthase--metabolism<br/>Humans<br/>Phosphorylases--metabolism<br/>Plasminogen Activators--pharmacology<br/>Protein Binding--drug effects<br/>Tamoxifen--pharmacology<br/>Tumor Cells, Cultured<br/>Tumor Suppressor Protein p53--biosynthesis